Hyderabad Telangana, India

Mittapelly Nagaraju

This inventor holds 1 USPTO granted patent. Top assignee: Mylan Laboratories Limited. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mittapelly Nagaraju. Retrieved from https://idiyas.com/inventor/mittapelly-nagaraju

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mittapelly Nagaraju: Innovator in Pharmaceutical Chemistry

Introduction

Mittapelly Nagaraju is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel processes for drug synthesis. His work is characterized by a commitment to innovation and excellence in the pharmaceutical industry.

Latest Patents

Nagaraju holds a patent for the synthesis of Aliskiren, a renin inhibitor. The patent outlines a novel process for the preparation of Aliskiren or its derivatives, along with its pharmaceutically acceptable salts. Additionally, the invention provides novel intermediates used in the preparation of Aliskiren. This patent highlights his expertise in creating effective pharmaceutical compounds.

Career Highlights

Nagaraju is currently employed at Mylan Laboratories Limited, a leading global pharmaceutical company. His role at Mylan allows him to apply his innovative ideas and contribute to the development of important medications. His work has been instrumental in advancing the company's research and development efforts.

Collaborations

Some of his notable coworkers include Rama Shankar and Vadali Lakshmana Rao. Their collaboration has fostered a productive environment for innovation and research within the company.

Conclusion

Mittapelly Nagaraju is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in drug synthesis. His contributions, particularly in the synthesis of Aliskiren, demonstrate his commitment to innovation in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…